The global burden of lower respiratory infections: making progress, but we need to do better
Open Access
- 1 November 2018
- journal article
- editorial
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 18 (11), 1162-1163
- https://doi.org/10.1016/S1473-3099(18)30407-9
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15The Lancet. Global Health, 2018
- Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure?The Lancet Respiratory Medicine, 2018
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015The Lancet Infectious Diseases, 2017
- Impact of pneumococcal conjugate vaccines for children in high- and non–high-income countriesExpert Review of Vaccines, 2017
- Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development GoalsThe Lancet, 2016
- Deconstructing the differences: a comparison of GBD 2010 and CHERG’s approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologiesBMC Infectious Diseases, 2015
- The Pneumonia Etiology Research for Child Health Project: A 21st Century Childhood Pneumonia Etiology StudyClinical Infectious Diseases, 2012